FDA Revises Plans On Drug Risk Communications
The U.S. Food and Drug Administration has released a new plan outlining efforts to improve communication with the public about the risks and benefits of drugs and other products regulated by...To view the full article, register now.
Already a subscriber? Click here to view full article